fidarestat and Complications of Diabetes Mellitus
fidarestat has been researched along with Complications of Diabetes Mellitus in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Alaparthi, MD; Bandaru, S; Chittineni, PR; Gopinath, G; Krupadanam, GLD; Pasala, VK; Perugu, S; Sagurthi, SR; Sankeshi, V | 1 |
Dong, F; Ren, J | 1 |
Other Studies
2 other study(ies) available for fidarestat and Complications of Diabetes Mellitus
Article | Year |
---|---|
Design and synthesis of chiral 2H-chromene-N-imidazolo-amino acid conjugates as aldose reductase inhibitors.
Topics: Aldehyde Reductase; Amino Acids; Animals; Benzopyrans; Blood Glucose; Catalytic Domain; Cataract; Diabetes Complications; Disease Models, Animal; Drug Design; Enzyme Activation; Enzyme Inhibitors; Imidazoles; Inhibitory Concentration 50; Molecular Docking Simulation; Rats; Stereoisomerism; Structure-Activity Relationship | 2016 |
Fidarestat improves cardiomyocyte contractile function in db/db diabetic obese mice through a histone deacetylase Sir2-dependent mechanism.
Topics: Aldehyde Reductase; Animals; Diabetes Complications; Enzyme Inhibitors; I-kappa B Proteins; Imidazolidines; In Vitro Techniques; Male; Mice; Mice, Obese; Myocardial Contraction; Myocytes, Cardiac; Naphthalenes; Obesity; Phosphorylation; Pyrones; Sirtuin 1; Sirtuins; Superoxides | 2007 |